ResearcherUniversity of California, San FranciscoActive in the last 2 years

Lisa Kirkemo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1686-6987; OpenAlex author ID A5038026321; NIH RePORTER profile ID 14677295. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 1
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 grant · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

Grants 1

Mechanistic Insights and Diagnostic Applications for Hypoxia-Induced Vasorin in Pancreatic Cancer F31CA247527 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

James A Wells · 2 shared papers, 2023–2025 · strength 0.59
- Paper Secreted HLA-Fc fusion profiles immunopeptidome in hypoxic PDAC and cellular senescence. DOI 10.1093/pnasnexus/pgad400 ↗
- Paper Hypoxia Induces Extensive Protein and Proteolytic Remodeling of the Cell Surface in Pancreatic Adenocarcinoma (PDAC) Ce… DOI 10.1021/acs.jproteome.4c01037 ↗
Nicholas J. Rettko · 1 shared paper, 2023 · strength 0.31
- Paper Secreted HLA-Fc fusion profiles immunopeptidome in hypoxic PDAC and cellular senescence. DOI 10.1093/pnasnexus/pgad400 ↗
Irene Lui · 1 shared paper, 2025 · strength 0.28
- Paper Hypoxia Induces Extensive Protein and Proteolytic Remodeling of the Cell Surface in Pancreatic Adenocarcinoma (PDAC) Ce… DOI 10.1021/acs.jproteome.4c01037 ↗
Rushika Miriam Perera · 1 shared paper, 2025 · strength 0.28
- Paper Hypoxia Induces Extensive Protein and Proteolytic Remodeling of the Cell Surface in Pancreatic Adenocarcinoma (PDAC) Ce… DOI 10.1021/acs.jproteome.4c01037 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.